Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last kr364.10 DKK
Change Today +5.50 / 1.53%
Volume 1.1M
NOVOB On Other Exchanges
New York
As of 6:36 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Lars Rebien Sørensen

Chief Executive Officer, President and Member of Executive Management,Novo Nordisk A/S
AgeTotal Calculated CompensationThis person is connected to 17 board members in 2 different organizations across 12 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Lars Rebien Sørensen has been the Chief Executive Officer of Novo Nordisk A/S since November 2000. Mr. Sørensen served as Chief Executive Officer and President of Danmarks Nationalbank. He served as an Equity Analyst at Handelsbanken Capital Markets, Research Division. Over the years, he has been stationed in several countries, including the Middle East and the United States. He has strong operational competencies and extensive knowledge within innovation, marketing ...

Read Full Background

Corporate Headquarters*

Novo Allé
Bagsvaerd, Capital Region of Denmark 2880


Phone: 45 44 44 88 88
Fax: 45 44 49 05 55

Board Members Memberships*

There is no Board Members Memberships data available.


Bachelor's Degree 1983
Copenhagen Business School
MS 1981
Den Kgl. Veterinær- og Landbohøjskole

Other Affiliations*

Annual Compensation*

Total Annual Compensationkr15,200,000

Stock Options*

All Other Compensationkr4,100,000

Total Compensation*

Total Annual Cash Compensationkr19,300,000
Total Short Term Compensationkr15,200,000
Other Long Term Compensationkr4,100,000
Total Calculated Compensationkr19,300,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVOB:DC kr363.70 DKK +5.10


Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVO NORDISK A/S-B, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at